These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23097887)

  • 1. [Kidney transplanted persons with malignant tumors is a growing patient group].
    Hellström V; Wilczek H; Roussos J; Lorant T; Enblad G; Nyberg F; Tufveson G
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1766-9. PubMed ID: 23097887
    [No Abstract]   [Full Text] [Related]  

  • 2. De novo immunosuppression with mammalian target of rapamycin inhibitors and posttransplantation malignancy in focus.
    Flechner S; Friend P; Campistol J; Weir M; Diekmann F; Russ G
    Transplant Proc; 2009; 41(6 Suppl):S42-4. PubMed ID: 19651296
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignancy in organ transplantation recipients.
    Sheil AG
    Transplant Proc; 1996 Jun; 28(3):1162. PubMed ID: 8658611
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrence of cancer after renal transplantation.
    Chapman JR; Sheil AG; Disney AP
    Transplant Proc; 2001; 33(1-2):1830-1. PubMed ID: 11267531
    [No Abstract]   [Full Text] [Related]  

  • 5. Malignancy following renal transplantation.
    Sheil AG; Disney AP; Mathew TG; Amiss N; Excell L
    Transplant Proc; 1992 Oct; 24(5):1946-7. PubMed ID: 1412921
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant neoplasias in renal transplantation recipients].
    Gómez-Roel X; León-Rodríguez E
    Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant neoplasms arising "de novo" after a kidney transplant. Our experience and a review of the literature].
    Tommasi GV; Arcuri V; Fontana I; Barabino M; Vassallo S; Casolino V; Valente U
    G Chir; 1994; 15(1-2):11-4. PubMed ID: 8018469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A familial form of nephrolithiasis in patients following kidney transplantation?].
    Trapeznikova MF; Kazimirov VG; Shcherbakova EO; Perlin DV; Urenkov SB
    Urol Nefrol (Mosk); 1996; (1):14-6. PubMed ID: 8659032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Solid tumors after kidney transplantation].
    Moal MC
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S214-7. PubMed ID: 19000890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant disease in renal transplant recipients--our experience.
    Blagojević-Lazić R; Radivojević D; Andrejević V; Dzamić Z; Acimović M; Milutinović D; Djurasić L; Hadzi-Djokić J
    Acta Chir Iugosl; 2012; 59(1):49-51. PubMed ID: 22924303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer and kidney transplantation].
    Montañés Medina P; Torrubia Romero FJ; González Baena AC; Martínez Rodríguez J; Cruz Navarro N
    Actas Urol Esp; 1994 Oct; 18(9):865-70. PubMed ID: 7817854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
    Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
    Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplant recipient's knowledge of posttransplant malignancy risk: implications for educational programs.
    Kauffman HM; Woodle ES; Cole EH; Paykin C;
    Transplantation; 2008 Apr; 85(7):928-33. PubMed ID: 18408569
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant neoplasms in patients subjected to renal transplantation].
    de Castro MC; Ianhez LE; Saldanha LB; Chocair PR; Fonseca JA; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(2):62-6. PubMed ID: 3912935
    [No Abstract]   [Full Text] [Related]  

  • 15. [Incidence of tumor pathology in a consecutive series of 497 kidney transplants in 431 patients].
    Portillo Martín JA; Correas Gómez MA; Gutiérrez Baños JL; Fernández Gómez JM; Masip Concepción TC; Monje Mirllas JM
    Arch Esp Urol; 1992 Sep; 45(7):655-8. PubMed ID: 1444610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in graft and patient survival after kidney transplantation in Sweden: caveats in interpretation of center effects when benchmarking.
    Elinder CG; Ekberg H; Bárány P; Fehrman-Ekholm I; Jensen G; Nordén G; Schön S; Wennberg L; Qureshi AR
    Transpl Int; 2009 Nov; 22(11):1051-7. PubMed ID: 19497064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complications following kidney transplantation--infections and malignant tumors].
    Hashimoto I; Aikawa I
    Nihon Rinsho; 1985 Jan; 43(1):48-52. PubMed ID: 3886962
    [No Abstract]   [Full Text] [Related]  

  • 18. [Malignant neoplasia and kidney transplantation. Retrospective analysis of data on the population having kidney transplantation with de novo neoplasia in the setting of the AIRT].
    Stallone G; Infante B; Schena A; Grandaliano G; Di Paolo S; Scolari MP; Stefoni S; Zanazzi M; Salvadori M; Savazzi AM; Albertazzi A; Cornella C; Turello E; Schena FP
    G Ital Nefrol; 2003; 20(6):611-4. PubMed ID: 14732914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of malignant tumors in renal transplant recipients receiving cyclosporine.
    Vilardell J; Oppenheimer F; Talbot-Wright R; Ricart MJ; Andreu J; Alcaraz A; Carretero P
    Transplant Proc; 1992 Oct; 24(5):1948. PubMed ID: 1412922
    [No Abstract]   [Full Text] [Related]  

  • 20. [The HLA phenotype and duodenal ulcers in patients following kidney transplantation].
    Potashov LV; Morozov VP; Bubnova LN; Savranskiĭ VM; Kabakov AB; Boriskova ME; Did-Zurabova ES
    Vestn Khir Im I I Grek; 1997; 156(5):23-8. PubMed ID: 9490528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.